Table 4 Univariate and multivariate cox regression analyses for prediction of RFS.
Univariate analysis | HR | 95% CI | p value |
|---|---|---|---|
Age (continuously coded) | 1.01 | 0.98–1.03 | 0.788 |
Gender | |||
Female versus male | 0.74 | 0.38–1.46 | 0.388 |
Clinical T-stage | |||
cT1 versus cTa/cTis | 1.37 | 0.57–3.019 | 0.469 |
Tumor grade | |||
High versus low | 1.75 | 0.70–4.36 | 0.229 |
Concomitant CIS | |||
Present versus absent | 0.81 | 0.41–1.59 | 0.541 |
Lymphovascular invasion | |||
Present versus absent | 1.08 | 0.56–2.05 | 0.824 |
Histological subtypes | |||
Present versus absent | 1.88 | 1.13–3.14 | 0.015* |
Pathological T-stage | |||
pT ≤ 1 | Reference | ||
pT = 2 | 2.08 | 1.03–4.21 | 0.043* |
pT ≥ 3 | 11 | 6.27–19.31 | <0.001*** |
Pathological N-status | |||
pNx | Reference | ||
pN0 | 0.33 | 0.17–0.57 | <0.001*** |
pN+ | 5.21 | 2.79–9.70 | <0.001*** |
Multivariate analysis | HR | 95% CI | p value |
|---|---|---|---|
Histological subtypes | |||
Absent | Reference | ||
Present | 1.21 | 0.71–2.05 | 0.489 |
Pathological T-stage | |||
pT ≤ 1 | Reference | ||
pT = 2 | 2.08 | 1.02–4.25 | 0.044* |
pT ≥ 3 | 9.37 | 4.85–18.10 | <0.001*** |
Pathological N-status | |||
pNx | Reference | ||
pN0 | 0.25 | 0.14–0.44 | <0.001*** |
pN+ | 1.03 | 0.49–2.16 | 0.929 |